Clinical trial

Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study

NCT02081638

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-04-18

PhasePHASE2

Study timeline

Study start (actual)2014-04-18Date precision: day

Registry last updated2020-12-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Human Immunodeficiency Virusunresolved

Interventions

AspirinDRUG · verified · RxNorm: aspirin

AtorvastatinDRUG · verified · RxNorm: atorvastatin

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Mapped research locations

MinneapolisMinnesota, United States1 BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02081638 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.